Skip to main content
58°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ARWR
Recent news which mentions ARWR
< Previous
1
2
3
Next >
HC Wainwright & Co. Maintains Buy Rating for Arrowhead Pharmaceuticals: Here's What You Need To Know
December 06, 2022
Tickers
ARWR
Tags
Market News
BZI/AAR/UPDATE
Analyst Ratings
From
Benzinga
Arrowhead Pharmaceuticals's Return On Capital Employed Overview
November 29, 2022
Tickers
ARWR
Tags
Benzinga
Earnings
BZI/ROCE
From
Benzinga
Analyst Ratings for Arrowhead Pharmaceuticals
November 29, 2022
Tickers
ARWR
Tags
Market News
BZI/AAR
Analyst Ratings
From
Benzinga
Earnings Scheduled For November 28, 2022
November 28, 2022
Tickers
ARWR
AVXL
AZEK
GLBS
Tags
BZI/UE
HTHT
Market News
From
Benzinga
Earnings Preview For Arrowhead Pharmaceuticals
November 25, 2022
Tickers
ARWR
Tags
Market News
Benzinga
Earnings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Tickers
ADCT
ALEC
ANNX
ARVN
Tags
PEN
AVTR
SHLS
From
Benzinga
What 7 Analyst Ratings Have To Say About Arrowhead Pharmaceuticals
August 08, 2022
Tickers
ARWR
Tags
BZI/AAR
Analyst Ratings
Benzinga
From
Benzinga
Arrowhead Pharmaceuticals (ARWR) Q3 2022 Earnings Call Transcript
August 05, 2022
Tickers
ARWR
Tags
ARWR
Recent Press Releases
Market News
From
Motley Fool
Arrowhead Pharmaceuticals: Q3 Earnings Insights
August 04, 2022
Tickers
ARWR
Tags
Earnings
BZI/Recaps
Benzinga
From
Benzinga
Where Arrowhead Pharmaceuticals Stands With Analysts
May 24, 2022
Tickers
ARWR
Tags
Market News
ARWR
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022
May 11, 2022
Tickers
AFRM
ALR
ARCT
ARRY
Tags
ONTF
ELS
CELH
From
Benzinga
Arrowhead Pharmaceuticals (ARWR) Q2 2022 Earnings Call Transcript
May 11, 2022
Tickers
ARWR
Tags
Recent Press Releases
Market News
ARWR
From
Motley Fool
Arrowhead Pharmaceuticals: Q2 Earnings Insights
May 10, 2022
Tickers
ARWR
Tags
Benzinga
Earnings
BZI/Recaps
From
Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Tickers
AGEN
ARWR
ATNX
AVGR
Tags
AVGR
VERU
IBB
From
Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
April 24, 2022
Tickers
ABBV
ALKS
ALNY
AMGN
Tags
IBB
ABBV
MRK
From
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 23, 2022
Tickers
ABBV
AMGN
ARWR
BSX
Tags
TLRY
BZI/AUOA
MRNA
From
Benzinga
The Best Russell 2000 Stocks to Buy Before they Rebound
February 15, 2022
Tickers
AMD
AMKR
ARWR
BJ
Tags
CROX
Market News
GSK
From
InvestorPlace
Arrowhead Pharmaceuticals (ARWR) Q1 2022 Earnings Call Transcript
February 03, 2022
Tickers
ARWR
Tags
Market News
Recent Press Releases
ARWR
From
Motley Fool
Arrowhead Pharmaceuticals's Return On Capital Employed Insights
February 03, 2022
Tickers
ARWR
Tags
Market News
Earnings
BZI/ROCE
From
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Tickers
ABMD
ARWR
BIIB
BMY
Tags
PRDS
NVO
General
From
Benzinga
Recap: Arrowhead Pharmaceuticals Q1 Earnings
February 03, 2022
Tickers
ARWR
Tags
BZI/Recaps
Market News
Earnings
From
Benzinga
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
February 02, 2022
Tickers
ABBV
ARWR
ATHX
AVIR
Tags
FDA
General
LOGC
From
Benzinga
Earnings Scheduled For February 2, 2022
February 02, 2022
Tickers
ABBV
ABC
ADTN
AFL
Tags
SGU
MXL
CPLP
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
Benzinga
ATHX
News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
January 19, 2022
Tickers
ABB
ADSE
AKAM
ALLY
Tags
KPRX
ZBH
LVS
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 14, 2022
Tickers
ARWR
BNTX
JNJ
MASI
Tags
MRNA
Benzinga
JNJ
From
Benzinga
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
November 23, 2021
Tickers
AADI
ABEO
AMYT
APLT
Tags
ARWR
Earnings
IBB
From
Benzinga
GlaxoSmithKline Pens $1B Pact For NASH Candidate With Arrowhead
November 23, 2021
Tickers
ARWR
GSK
Tags
GSK
Biotech
Market News
From
Benzinga
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
November 23, 2021
Tickers
ALNY
ARWR
DRNA
JNJ
Tags
NVO
ARWR
NVS
From
Motley Fool
Arrowhead Pharmaceuticals, inc (ARWR) Q4 2021 Earnings Call Transcript
November 22, 2021
Tickers
ARWR
Tags
ARWR
Market News
Recent Press Releases
From
Motley Fool
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.